Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 76420-319
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 76420-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Im-2 (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 02)
This text provides information about Zolpidem plasma concentrations measured in ng/mL. It compares the levels between 12.5 mg zolpidem tartrate extended-release tablets and 10 mg zolpidem tartrate immediate release over a period of time in hours. The data points out the concentration levels at different time intervals.*
Label (Label 12 5mg)
Description: This is information about Zolpidem Tartrate ER Tablets in 12.5 mg strength, with different packaging sizes and quantities. The text includes details such as NDC numbers, storage instructions, and lot numbers for tracking and quality control purposes. It is important to keep these tablets out of reach of children and store them at a controlled room temperature. The provided information is essential for managing inventory and ensuring the safe and proper use of the medication.*
6.25mg (Label 6 25mg)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.